Innoviva financials
$21.11−0.57%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $411.3M | $358.7M | $310.5M | $337.7M | $393.7M | $336.8M | $266.6M | $261.0M | $217.2M | $133.6M |
| Gross profit | $307.7M | $296.2M | $246.0M | $323.9M | $393.7M | $336.8M | $266.6M | $261.0M | $217.2M | $133.6M |
| Gross margin | 74.8% | 82.6% | 79.2% | 95.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $163.7M | $166.9M | $113.9M | $480.1M | $376.9M | $321.1M | $251.9M | $238.3M | $183.6M | $109.0M |
| Net income | $271.2M | $23.4M | $179.7M | $213.9M | $265.9M | $224.4M | $157.3M | $395.1M | $134.1M | $59.5M |
| Net margin | 65.9% | 6.5% | 57.9% | 63.3% | 67.5% | 66.6% | 59.0% | 151.4% | 61.8% | 44.6% |
| Diluted EPS | $3.30 | $0.36 | $2.20 | $2.37 | $2.87 | $2.02 | $1.43 | $3.53 | $1.17 | $0.53 |
| EBITDA | $204.0M | $206.7M | $149.6M | $218.9M | $390.8M | $335.0M | $265.8M | $252.1M | $197.6M | $122.9M |
| Operating cash flow | $196.9M | $188.7M | $141.1M | $201.7M | $363.8M | $313.1M | $257.5M | $223.9M | $142.1M | $61.2M |
| Free cash flow | $195.8M | $188.4M | $140.7M | $201.7M | $363.8M | $313.1M | $257.4M | $223.9M | $142.1M | $60.9M |
| Diluted shares | 84.8M | 74.2M | 86.9M | 95.2M | 94.3M | 113.6M | 113.4M | 113.4M | 119.9M | 123.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $550.9M | $305.0M | $193.5M | $291.0M | $201.5M | $246.5M |
| Short-term investments | $15.7M | $107.5M | $0.00 | $0.00 | — | — |
| Total debt | $259.3M | $451.8M | $449.7M | $544.7M | $398.8M | $389.7M |
| Total assets | $1.64B | $1.30B | $1.24B | $1.23B | $926.4M | $999.6M |
| Total liabilities | $462.3M | $609.9M | $568.6M | $665.7M | $400.5M | $391.7M |
| Shareholders' equity | $1.17B | $691.2M | $675.0M | $565.8M | $525.9M | $607.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology